K. Walker et al., DEVELOPMENT OF HYPERTHERMIA FOLLOWING INTRACEREBROVENTRICULAR ADMINISTRATION OF ENDOTOXIN IN THE RAT - EFFECT OF KININ B-1 AND B-2 RECEPTORANTAGONISTS, British Journal of Pharmacology, 117(4), 1996, pp. 684-688
1 E. coli lipopolysaccharide (LPS) produced a dose-dependent (dose ran
ge: 0.02-150 mu g) increase in rat core temperature that was maximal 6
h after intracerebroventricular (i.c.v.) administration. LPS (200 ng)
increased core temperature by 1.0+/-0.2 degrees C, 6 h following admi
nistration, as compared to vehicle-treated controls (-0.2+/-0.2 degree
s C). 2 LPS-induced (200 ng) hyperthermia was prevented by co-administ
ration of the bradykinin (BK) B-2 receptor antagonist, Hoe 140 (10 and
30 pmol, i.c.v.) or by indomethacin (10 nmol, i.c.v.). 3 Systemic adm
inistration of Hoe 140 at doses up to 1 mu mol kg(-1), s.c., did not a
ttenuate LPS-induced (200 ng, i.c.v.) hyperthernia. However, LPS hyper
thermia was significantly reduced by systemic administration of indome
thacin (1 mu mol kg(-1), i.v.). 4 Co-administration of the selective B
-1 receptor antagonists, [des-Arg(9), Leu(8)]BK (0.1-1 nmol, i.c.v.) o
r [des-Arg(10)] Hoe 140 (0.1-1 nmol, i.c.v.), did not prevent LPS-indu
ced hyperthermia. 5 It is concluded that the development of hypertherm
ia following central administration of endotoxin requires activation o
f central, but not peripheral bradykinin B-2 receptors. The formation
of kinins within the CNS may be an important initial component of CNS
inflammation following infection.